4th Quarter - Report

TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009"; and HR 1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR 1260 "The Patent Refrom Act of 2009"

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), H.R. 1706 (111th)

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit including all such provisions in HR 422 "To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit. International tax treaties and the ratification of the Second Protocol to the Income Tax Treaty between the U.S. and France.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 422 (111th)

Health Issues HCR

Provisions and issues related to patient access to and the coverage, payment, and pricing of pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to cancer awareness and access to treatment, issues and provisions related to the 340B federal Safety Bet Drug Pricing Programs, isses and provisions related to comparative effectiveness, and issues and provisions related to the Independent Medicare Advisory Committee in HR 3590 "The Patient Protection and Affordable Care Act." All provisions of SAmdt2952 to HR 3590. General issues related to the Medicare Part D program including patient access to pharmaceuticals, issues related to awareness of atrial fibrillation and access to treatment, issues related to cancer awareness and access to treatment

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (111th)

Medicare/Medicaid MMM

Issues related to the Medicaid Program Medicare Part B Reimbursement

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.